Search research articles
Contact Us
Filters
Showing results (51-60 of 156) with videos related to
Page
of 16
Sort By:
Anaesthesia
|
June 7, 2003
Giant axonal neuropathy and anaesthesia
P Diagos, J A G Bos, A Verrips, et al.
Neuroimage
|
February 26, 2011
Structural, functional and molecular imaging of the brain in primary focal dystonia--a review
E Zoons, J Booij, A J Nederveen, et al.
Journal of Medical Ethics
|
December 25, 2012
A plea for end-of-life discussions with patients suffering from Huntington's disease: the role of the physician
Suzanne J Booij, Dick P Engberts, Verena Rödig, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 15, 1999
Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm
J B Habraken, J Booij, P Slomka, et al.
Journal of Neurology
|
September 3, 2014
Thinking about the end of life: a common issue for patients with Huntington's disease
Suzanne J Booij, Aad Tibben, Dick P Engberts, et al.
Journal of Huntington'S Disease
|
July 27, 2014
Euthanasia and advance directives in Huntington's disease: qualitative analysis of interviews with patients
Suzanne J Booij, Verena Rödig, Dick P Engberts, et al.
AJNR. American Journal of Neuroradiology
|
June 28, 2000
MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings
L Reneman, J B Habraken, C B Majoie, et al.
Paediatric Anaesthesia
|
July 26, 2002
Time-course of action of rocuronium 0.3 mg.kg-1 in children with and without endstage renal failure
Jacques J Driessen, Eric N Robertson, Jan Van Egmond, et al.
Diabetes & Metabolism
|
July 4, 2016
Dopaminergic Effects on Brown Adipose Tissue (DEBAT): A prospective physiological study
L Bahler, H J Verberne, M R Soeters, et al.
European Journal of Nuclear Medicine
|
April 25, 2000
[123I]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication
J Lavalaye, R J Knol, K de Bruin, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 156) with videos related to
Sort By:
Page
of 16
Anaesthesia
|
June 7, 2003
Giant axonal neuropathy and anaesthesia
P Diagos, J A G Bos, A Verrips, et al.
Neuroimage
|
February 26, 2011
Structural, functional and molecular imaging of the brain in primary focal dystonia--a review
E Zoons, J Booij, A J Nederveen, et al.
Journal of Medical Ethics
|
December 25, 2012
A plea for end-of-life discussions with patients suffering from Huntington's disease: the role of the physician
Suzanne J Booij, Dick P Engberts, Verena Rödig, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 15, 1999
Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm
J B Habraken, J Booij, P Slomka, et al.
Journal of Neurology
|
September 3, 2014
Thinking about the end of life: a common issue for patients with Huntington's disease
Suzanne J Booij, Aad Tibben, Dick P Engberts, et al.
Journal of Huntington'S Disease
|
July 27, 2014
Euthanasia and advance directives in Huntington's disease: qualitative analysis of interviews with patients
Suzanne J Booij, Verena Rödig, Dick P Engberts, et al.
AJNR. American Journal of Neuroradiology
|
June 28, 2000
MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings
L Reneman, J B Habraken, C B Majoie, et al.
Paediatric Anaesthesia
|
July 26, 2002
Time-course of action of rocuronium 0.3 mg.kg-1 in children with and without endstage renal failure
Jacques J Driessen, Eric N Robertson, Jan Van Egmond, et al.
Diabetes & Metabolism
|
July 4, 2016
Dopaminergic Effects on Brown Adipose Tissue (DEBAT): A prospective physiological study
L Bahler, H J Verberne, M R Soeters, et al.
European Journal of Nuclear Medicine
|
April 25, 2000
[123I]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication
J Lavalaye, R J Knol, K de Bruin, et al.
Page
of 16